New development in the treatment of breast cancer. II. Future anti-HER2 therapy
Yamashita, T.; Iwata, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(13): 2551-2554
2009
ISSN/ISBN: 0385-0684 PMID: 20104676 Document Number: 630555
Document emailed within 1 workday
Related Documents
Mano, H. 2015: Development of anti-cancer drug: past and future Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 11-15Tominaga, T. 1999: Recent development of oral anti-cancer drugs for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(3): 301-307
Sonoo, H. 2007: Current status and future prospects for breast cancer therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 6: 391-395
Ecker-Schlipf, B. 1994: Anti-hormonal therapy in breast cancer Medizinische Monatsschrift für Pharmazeuten 17(8): 247-250
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Okano, M.; Ohtake, T.; Saji, S. 2016: Combination Therapy of Molecular-Targeted Drugs for Breast Cancer -- their Potential in the Future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(4): 398-403
Osaki, A.; Saeki, T. 2011: Current status and future direction of postoperative adjuvant therapy in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(9): 1406-1411
Brand, F-Xavier.; Ravanel, N.; Gauchez, A-Sophie.; Pasquier, D.; Payan, R.; Fagret, D.; Mousseau, M. 2006: Prospect for anti-HER2 receptor therapy in breast cancer Anticancer Research 26(1b): 463-470
Kaufmann, M.; Jonat, W.; Eiermann, W.; Maass, H.; Bastert, G. 1990: Breast saving operation and adjuvant therapy of breast cancer. Report of the National Institute of Health (NIH) consensus development conference, Washington, D.C., USA, 18-21 June 1990 Onkologie 13(5): 394-396
Badellino, F.; Vecchio, C.; Rosato, F. 1998: Treatment of breast cancer. Future perspectives Minerva Chirurgica 53(1-2): 1-7
Hirai, F. 2015: III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 940-943
Von Minckwitz, G.; Loibl, S.; Untch, M. 2012: What is the current standard of care for anti-HER2 neoadjuvant therapy in breast cancer? Oncology 26(1): 20-26
Hayes, D.F.; Henderson, I.C.; Shapiro, C.L. 1995: Treatment of metastatic breast cancer: present and future prospects Seminars in Oncology 22(2 Suppl 5: 5
Tokuda, Y. 2014: The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives Nihon Geka Gakkai zasshi 115(1): 17-21
Caceres, G.; Dauphinee, M.J.; Eisele, L.E.; MacColl, R.; Mizejewski, G.J. 2002: Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein Anticancer Research 22(5): 2817-2820
Barker, S. 2006: Non-steroidal anti-estrogens in the treatment of breast cancer Current Opinion in Investigational Drugs 7(12): 1085-1091
Tsuno, H.; Okaji, Y.; Tanaka, M.; Nagawa, H.; Takahashi, K. 2005: Development of a novel anti-cancer therapy based on targeting of tumor microvessel endothelial cells Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 527-533
Ormenisan, C.; Kubik, M.; Legrand, S.; Kraemer, D.; Smotherman, C.; Masood, S. 2015: The potential of ki67 and p53 assessment in development of individualized targeted therapy in breast cancer patients Pathologica 107(3-4): 177-180
Elamin, M.H.; Elmahi, A.B.; Daghestani, M.H.; Al-Olayan, E.M.; Al-Ajmi, R.A.; Alkhuriji, A.F.; Hamed, S.S.; Elkhadragy, M.F. 2019: Synergistic Anti-Breast-Cancer Effects of Combined Treatment with Oleuropein and Doxorubicin in Vivo Alternative Therapies in Health and Medicine 25(3): 17-24
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712